UB
Ute Katharina Bartels
Research areas: Medicine · Oncology · Glioma Diagnosis and Treatment · Acute Lymphoblastic Leukemia research · Childhood Cancer Survivors' Quality of Life
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (14)
- When Does Infantile Nystagmus Predict Optic Pathway Glioma? Save
- Quality of Life Outcomes in Children Undergoing Reirradiation for Recurrent Brain Tumors: A Prospective Study Save
- Optimizing an exercise training program in pediatric brain tumour survivors: Does timing postradiotherapy matter? Save
- Stalking the stalk: Isolated pituitary stalk thickening and predictive factors for proliferative disease Save
- Nivolumab With or Without Ipilimumab in Pediatric Patients With High-Grade CNS Malignancies: Efficacy, Safety, Biomarker, and Pharmacokinetics: CheckMate 908 Save
- Characteristics of children ≤36 months of age with DIPG: A report from the international DIPG registry Save
- Pediatric Brain Tumor Survivors’ Understanding of Friendships: A Qualitative Analysis of ADOS-2 Interview Responses Save
- Phase II trial of response-based radiation therapy for patients with localized germinoma: a Children’s Oncology Group study Save
- Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry Save
- Characteristics of patients ≥10 years of age with diffuse intrinsic pontine glioma: a report from the International DIPG/DMG Registry Save
- Adolescent and young adult glioma: systematic review of demographic, disease, and treatment influences on survival Save
- Prognostic factors related to overall survival in adolescent and young adults with medulloblastoma: A systematic review Save
- Selumetinib for optic pathway glioma: Seeing through the fog, (not yet) the end of the tunnel? Save
- Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03) Save